Literature DB >> 18809936

Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Noriyuki Nagano1, Yukiko Nagano, Kouji Kimura, Kiyoko Tamai, Hideji Yanagisawa, Yoshichika Arakawa.   

Abstract

The recent emergence of group B streptococcal isolates exhibiting increased penicillin MICs at the Funabashi Municipal Medical Center and other hospitals in Japan prompted a comparative analysis of the penicillin-binding proteins (PBPs) from those strains with the PBPs from penicillin-susceptible strains comprising four neonatal invasive strains isolated from 1976 to 1988 and two recent isolates. The PBP sequences of the penicillin-susceptible strains were highly conserved, irrespective of their isolation date. Of six strains with reduced susceptibility to penicillin (penicillin MICs, 0.25 to 0.5 mug/ml), strains R1, R2, R5, and R6 shared a unique set of five amino acid substitutions, including V405A adjacent to the (402)SSN(404) motif in PBP 2X and one in PBP 2B. The remaining two strains, R3 and R4, shared several substitutions, including Q557E adjacent to the (552)KSG(554) motif in PBP 2X, in addition to the substitutions in PBP 2B, which are commonly found among penicillin-insusceptible strains. Strains R7 and R8, which had a penicillin MIC of 1 mug/ml, shared a unique set of eight amino acid substitutions (two in PBP 2X; two in PBP 2B, including G613R adjacent to the (614)KTG(616) motif; three in PBP 1A; and one in PBP 2A), and the Q557E substitution in PBP 2X was common to R3 and R4. The binding of Bocillin FL was reduced or not detected in some PBPs, including PBP 2X of penicillin-insusceptible strains, but no significant reduction in the level of pbp2x transcription was found in such strains. The results of phylogenetic comparative analyses imply the absence of epidemic penicillin-insusceptible strains, and several genetic lineages of penicillin-insusceptible strains have been independently emerging through the accumulation of mutations in their pbp genes, especially in pbp2x.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809936      PMCID: PMC2592870          DOI: 10.1128/AAC.00596-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

3.  Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.

Authors:  Wehbeh Wehbeh; Roberto Rojas-Diaz; Xinying Li; Noriel Mariano; Louise Grenner; Sorana Segal-Maurer; Barbara Tommasulo; Karl Drlica; Carl Urban; James J Rahal
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 6.  Group B streptococcus.

Authors:  A Schuchat
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

7.  First molecular characterization of group B streptococci with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Satowa Suzuki; Jun-ichi Wachino; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Noriyuki Nagano; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

8.  Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.

Authors:  Samira Dahesh; Mary E Hensler; Nina M Van Sorge; Robert E Gertz; Stephanie Schrag; Victor Nizet; Bernard W Beall
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

9.  Genetic diversity of the C protein beta-antigen gene and its upstream regions within clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Ryuichi Nakano; Ryoichi Okamoto; Matsuhisa Inoue
Journal:  Microbiology (Reading)       Date:  2006-03       Impact factor: 2.777

Review 10.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  24 in total

1.  Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.

Authors:  Hirotsugu Banno; Kouji Kimura; Yosuke Tanaka; Hiromitsu Kitanaka; Wanchun Jin; Jun-ichi Wachino; Keiko Yamada; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

2.  A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing Myositis.

Authors:  Randall J Olsen; Luchang Zhu; James M Musser
Journal:  Am J Pathol       Date:  2020-05-11       Impact factor: 4.307

3.  Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Masami Toyama; Kouji Kimura; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

4.  Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread.

Authors:  James M Musser; Stephen B Beres; Luchang Zhu; Randall J Olsen; Jaana Vuopio; Hanne-Leena Hyyryläinen; Kirsi Gröndahl-Yli-Hannuksela; Karl G Kristinsson; Jessica Darenberg; Birgitta Henriques-Normark; Steen Hoffmann; Dominque A Caugant; Andrew J Smith; Diane S J Lindsay; David M Boragine; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.

Authors:  Jussara K Palmeiro; Libera M Dalla-Costa; Sérgio E L Fracalanzza; Ana C N Botelho; Keite da Silva Nogueira; Mara C Scheffer; Rosângela S L de Almeida Torres; Newton Sérgio de Carvalho; Laura Lúcia Cogo; Humberto M F Madeira
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

6.  Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.

Authors:  Jean Longtin; Christie Vermeiren; Dea Shahinas; Gurdip Singh Tamber; Allison McGeer; Donald E Low; Kevin Katz; Dylan R Pillai
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

7.  Correlation between Group B Streptococcal Genotypes, Their Antimicrobial Resistance Profiles, and Virulence Genes among Pregnant Women in Lebanon.

Authors:  Antoine Hannoun; Marwa Shehab; Marie-Therese Khairallah; Ahmad Sabra; Roland Abi-Rached; Tony Bazi; Khalid A Yunis; George F Araj; Ghassan M Matar
Journal:  Int J Microbiol       Date:  2010-02-02

8.  Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin.

Authors:  Marisa Haenni; Laure Galofaro; Mathilde Ythier; Marlyse Giddey; Paul Majcherczyk; Philippe Moreillon; Jean-Yves Madec
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

9.  High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan.

Authors:  Hirotsugu Banno; Kouji Kimura; Tomomi Seki; Wanchun Jin; Jun-Ichi Wachino; Keiko Yamada; Noriyuki Nagano; Yoshichika Arakawa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-17       Impact factor: 3.267

10.  Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007.

Authors:  Neelay J Kothari; Craig A Morin; Anita Glennen; Delois Jackson; Jane Harper; Stephanie J Schrag; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.